Thus, the detection of HPV infection and histopathological determination of p16 protein expression in tumor samples are expected to gain importance in clinical settings and marks a major shift in managing HNSCC cancer patients. The gene discussed is CDKN2A; the disease is head and neck squamous cell carcinoma.